The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I study of CFI-402257, an oral TTK inhibitor, in patients with advanced solid tumors.
 
David W. Cescon
Consulting or Advisory Role - Genomic Health
Research Funding - GlaxoSmithKline (Inst); Merck (Inst); Novartis (Inst); Roche/Genentech (Inst)
 
Aaron Richard Hansen
No Relationships to Disclose
 
Albiruni Ryan Abdul Razak
No Relationships to Disclose
 
Lee-Anne Stayner
No Relationships to Disclose
 
John Frederick Hilton
No Relationships to Disclose
 
Daniel John Renouf
Honoraria - Amgen; Celgene
Consulting or Advisory Role - Celgene; Shire
Research Funding - Bayer
 
Trisha Denny
No Relationships to Disclose
 
Graham Fletcher
No Relationships to Disclose
 
Tak W Mak
No Relationships to Disclose
 
Mark R Bray
No Relationships to Disclose
 
Philippe L Bedard
No Relationships to Disclose